Sunday, May 28, 2023

Email id:, Contact Us : +91-9871552944

Home Health Care Global Smart Insulin Pens Market Research Report: Ken Research

Global Smart Insulin Pens Market Research Report: Ken Research

Major players in the smart insulin pens market are Companion Medical, Eli Lilly and Company, Novo Nordisk A/S, Diamesco Co. Ltd., Emperra GmbH E-Health Technologies, Digital Medics Pvt Ltd., F. Hoffmann-La Roche AG, Insulet Corporation, Jiangsu Delfu medical device Co. Ltd., and Bigfoot biomedica.

The global smart insulin pens market is expected to grow from USD 75.8 million in 2019 and to USD 77 million in 2020 at a growth rate of 1.6%. The slow growth is due to disruption in supply chains and restrictions on trade of medical products across countries owing to the COVID-19 outbreak. The market is then expected to grow and reach USD 98.4 million in 2023 at CAGR of 8.51%.

The smart insulin pens market consists of sales of smart insulin pens which allows to dial the insulin dose accurately and related products. The companies manufacturing the smart insulin pens are primarily engaged in designing and manufacturing of first- and second-generation smart insulin pens which are either reusable or pre-filled for the application of delivering accurate insulin dose in Type 1 Diabetes and Type 2 Diabetes. The revenue generated by these companies is through sales of these pens to Hospitals & Clinics, Ambulatory surgical centres and Home care settings.

North America was the largest region in the smart insulin pens market in 2019. Asia Pacific was the fastest growing region in the smart insulin pens market in the forecast period.

In February 2020, Senseonics a US-based medical technology company which primarily focuses on the design, development and commercialization of glucose monitoring products announced partnership with Companion Medical. The partnership will benefit both the companies by integrating Eversense CGM System with the InPen smart system for accurate insulin delivery. Companion Medical is a US-based company which aims at achieving desirable diabetes outcomes and manufactured InPen which is the US first FDA approved insulin pen.

Diabetics may be prescribed with two types of insulin for better control over blood glucose levels. They usually prefer a pre-mixed insulin (combination) or a method in which the insulin doses could be mixed and once puncture is necessary to deliver the different types of insulin doses required. Multiple punctures for the insulin delivery can lead to poor adherence of the medication which in turn results in poor glycemic control. In 2018, a study published states that poor glycemic control (A1c>7%) was reported in 68% of respondents and there was an association between A1c >7% and poor adherence levels. Dislike towards injection to a large extent and needle phobia can result in poor adherence levels. It is estimated that over 10% of population have needle phobia. These factors can reduce the adherence of smart insulin pens where two types of insulin can’t be mixed and results in multiple needle punctures which thereby effect the purpose of the insulin being administered which is expected to hinder the market growth.

The next generation smart insulin pens go far beyond memory storage. They help in calculating personalized doses, track glucose continuously and connects with apps of smartphones to visualize the data. In 2019, Novo Nordisk and Abbott partnered to integrate insulin dose data into the digital health tools which aims at connecting key technologies such as continuous glucose monitoring and insulin pens thus simplifying diabetes management. The Novo Pen 6 and the Novo Pen Echo Plus pens will be able to connect to the Dexcom G6 CGM and the Diasend diabetes management platform (Glooko). In 2019, Companion Medical announced that the Bluetooth-enabled InPen which takes away the guesswork from dosing of insulin with an in-app bolus calculator that uses precise carbohydrate ratios and correction factors and calculates the personalized insulin doses. This enhances the ease of usage of smart insulin pens which is expected to boost the market.

Accurate dose of insulin can be achieved than vial or a syringe with an insulin pen. For kids who need to take insulin during school time and visually impaired diabetic patients, an accurate dose of insulin can even be pre-set over the dosage dial which helps in accurate delivery of dose at the time of injection. Echo Plus by Novo Nordisk which is a pediatric friendly insulin pen allows even half-unit dosing with a maximum of 30 units. Huma Pen Luxury HD from Lilly allows the delivery of insulin in half-unit increments and Novo Pen Junior-Insulin Pen by Novo Nordisk can deliver highly accurate doses of insulin and finely adjusts small doses even half-unit increments. The accurate adjustments and delivery of doses of insulin can avoid either over-dosing or low-dosing of the drug which is expected to increase the demand of smart insulin pens and drive the market growth.

For More Information, Click on the Link Below:-

Global Smart Insulin Pens Market

Related Report:-

World Smart Insulin Pens Market Research Report 2025 (Covering USA, Europe, China, Japan, India and etc)

Contact Us:-

Ken Research

Ankur Gupta, Head Marketing & Communications



Global Nutraceuticals Market is forecasted to reach a market size of ~US$ 500 billion: Ken Research

Buy Now What Is the Size of Global Nutraceuticals Industry? Global Nutraceuticals market is growing at a CAGR of ~% in 2017-2022 and is expected to...

Which key factors in Thailand Ophthalmology Market can help it to cross a revenue of more than THB 10 Th by 2025? : Ken...

Buy Now Eye Consultations and Eye Surgeries are expected to grow at a CAGR of about 4% and 3% respectively by 2025, as per a report by Ken Research 1....

The KSA Fitness Market generated over $800 Mn Revenue in 2020 driven by evolving service offerings by fitness centers and government policies such as...

Buy Now Saudi Arabia’s health and social affairs budget for 2019 outlines an 8% increase to USD 46 Bn as compared to USD 42 Bn...

Most Popular

Global Nutraceuticals Market is forecasted to reach a market size of ~US$ 500 billion: Ken Research

Buy Now What Is the Size of Global Nutraceuticals Industry? Global Nutraceuticals market is growing at a CAGR of ~% in 2017-2022 and is expected to...

Global Epoxy Resin Market is expected to reach ~USD 15 Bn by 2028F: Ken Research

Buy Now Global Epoxy Resin Market By End-User The Global Epoxy Resin market is segmented by End-user into Building & Construction, Transportation, Consumer Goods, Wind Energy, Aerospace,...

The Global E-Learning market is anticipated to exceed USD 400 billion 2027 – Ken Research

Buy Now Competition Scenario in Global E-Learning Market In Global E-learning Market there are several players operating in the market, and top players account for a...

Global Network Telemetry Market is expected to record a positive CAGR of ~20% during the forecast period (2022-2028): Ken Research

Buy Now What Is the Size of Global Network Telemetry Industry? Global Network Telemetry market is growing at a CAGR of ~% in 2017-2022 and is...